QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NASDAQ:KRTX

Karuna Therapeutics - KRTX SEC Filings & 10K Form

$200.79
-26.16 (-11.53%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$196.49
$217.01
50-Day Range
$203.44
$236.82
52-Week Range
$92.26
$278.25
Volume
1.15 million shs
Average Volume
338,669 shs
Market Capitalization
$6.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$259.47

Recent Karuna Therapeutics SEC Filings

DateFilerForm TypeView
12/06/2022
5:36 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2022
4:08 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
5:31 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
5:47 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2022
5:37 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2022
4:13 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2022
4:04 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4/A
10/12/2022
4:01 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
6:25 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2022
3:08 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2022
3:31 PM
Karuna Therapeutics (Subject)
PureTech Health LLC (Filed by)
Form SC 13D/A
08/11/2022
4:19 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2022
4:17 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2022
4:03 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2022
3:49 PM
Karuna Therapeutics (Filer)
Form 424B5
08/08/2022
4:43 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2022
4:18 PM
Karuna Therapeutics (Filer)
Form 424B5
08/08/2022
5:59 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2022
5:50 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2022
5:43 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2022
5:30 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2022
12:23 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2022
6:06 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2022
3:44 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
3:41 PM
Karuna Therapeutics (Issuer)
Torres Denice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
3:40 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
3:39 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
3:38 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
3:31 PM
COUGHLIN CHRISTOPHER J (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2022
3:42 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2022
3:45 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:32 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2022
5:57 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2022
5:39 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2022
6:05 AM
Karuna Therapeutics (Filer)
Form DEFA14A
04/27/2022
6:04 AM
Karuna Therapeutics (Filer)
Form DEF 14A
04/21/2022
6:04 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2022
3:46 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
4:50 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:28 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2021
6:44 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2021
6:43 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
6:00 AM
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
5:42 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2021
5:48 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
4:31 PM
Karuna Therapeutics (Issuer)
Preston Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
3:35 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
3:34 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
3:31 PM
HEALY JAMES (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
3:30 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
3:28 PM
JONAS JEFFREY M (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2021
6:02 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2021
6:01 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
8:13 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
4:51 PM
Karuna Therapeutics (Issuer)
OLSON LAURIE J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2021
3:45 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
4:29 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
4:28 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
6:00 AM
Karuna Therapeutics (Filer)
Karuna Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
5:46 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2021
6:44 AM
Karuna Therapeutics (Filer)
Form DEFA14A
04/27/2021
6:41 AM
Karuna Therapeutics (Filer)
Form DEF 14A
04/15/2021
4:20 PM
Karuna Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
4:18 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2021
3:29 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
6:25 PM
Karuna Therapeutics (Issuer)
Preston Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
3:47 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
3:21 PM
Karuna Therapeutics (Filer)
Form 424B5
03/01/2021
5:05 AM
Karuna Therapeutics (Filer)
Form 424B5
02/25/2021
6:00 AM
Karuna Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
5:30 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2021
4:00 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
4:00 PM
Brannan Stephen K. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
4:00 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
4:00 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:23 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
11:24 AM
Karuna Therapeutics (Subject)
Form SC 13G
02/10/2021
5:15 AM
Karuna Therapeutics (Subject)
PureTech Health plc (Filed by)
Form SC 13D/A
02/10/2021
5:14 AM
Karuna Therapeutics (Issuer)
PureTech Health LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
9:25 AM
FMR LLC (Filed by)
Karuna Therapeutics (Subject)
Form SC 13G/A
02/01/2021
3:23 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
12:25 PM
ARCH Venture Fund IX, L.P. (Filed by)
Karuna Therapeutics (Subject)
Form SC 13D/A
01/19/2021
12:25 PM
Karuna Therapeutics (Subject)
Karuna Therapeutics (Subject)
Form SC 13D/A
01/15/2021
3:05 PM
Karuna Therapeutics (Issuer)
PAUL STEVEN M (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/12/2021
3:45 PM
Karuna Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
3:44 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
3:34 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
3:31 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
4:09 PM
Ignelzi Troy A. (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
4:14 PM
Karuna Therapeutics (Issuer)
Torres Denice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
4:02 PM
Karuna Therapeutics (Issuer)
Torres Denice (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2020
3:57 PM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2020
4:11 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
4:10 PM
Karuna Therapeutics (Issuer)
Pande Atul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:11 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:07 PM
Karuna Therapeutics (Issuer)
Wheadon David E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2020
8:17 AM
Karuna Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
5:15 PM
Karuna Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:14 PM
ARCH Venture Fund IX Overage, L.P. (Reporting)
ARCH Venture Fund IX, L.P. (Reporting)
ARCH Venture Partners IX Overage, L.P. (Reporting)
ARCH Venture Partners IX, L.P. (Reporting)
ARCH Venture Partners IX, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Karuna Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
3:24 PM
Karuna Therapeutics (Issuer)
Miller Andrew Craig (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:KRTX) was last updated on 12/6/2022 by MarketBeat.com Staff